CRP and pulmonary hypertension: Another network meta-analysis study suggested that statins reduced the risk of all-cause and cause-specific mortality, pulmonary hypertension, and the level of C-reactive protein (CRP), IL6, IL8, and TNF-α in COPD patients [21].